Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPR | P35270 | 4/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 4/20 | 1.00 |
| ▸ | NOTUM | Q6P988 | 3/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | BLM | P54132 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | IDO1 | P14902 | 1/20 | 1.00 |
| ▸ | MTNR1A | P48039 | 6/20 | 0.76 |
| ▸ | MTNR1B | P49286 | 6/20 | 0.76 |
| ▸ | MEN1 | O00255 | 3/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.70 |
| ▸ | NQO2 | P16083 | 3/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.70 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.70 |
| ▸ | MPO | P05164 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetylserotonin SCHEMBL30295379 | 1.00 | SPR (1.00) | SPRKDM4ECYP1A2NOTUMCYP2D6 | |
| Acetylserotonin SCHEMBL422165 | 1.00 | SPR (1.00) | SPRKDM4ECYP1A2NOTUMCYP2D6 | |
| Acetylserotonin SCHEMBL29669245 | 0.99 | SPR (0.97) | SPRKDM4ECYP1A2NOTUMCYP2D6 | |
| Acetylserotonin SCHEMBL31488730 | 0.99 | SPR (0.97) | SPRKDM4ECYP1A2NOTUMCYP2D6 | |
| Acetylserotonin SCHEMBL28475510 | 0.93 | SPR (0.86) | SPRKDM4ECYP1A2NOTUMCYP2D6 | |
| Acetylserotonin SCHEMBL28474145 | 0.93 | SPR (0.86) | SPRKDM4ECYP1A2NOTUMCYP2D6 | |
| Acetylserotonin SCHEMBL7569197 | 0.91 | SPR (0.83) | SPRKDM4ECYP1A2NOTUMCYP2D6 | |
| SCHEMBL1960963 | 0.87 | SPR (0.78) | SPRKDM4ECYP1A2NOTUMCYP2D6 | |
| SCHEMBL7100086 | 0.86 | SPR (0.76) | SPRKDM4ECYP1A2NOTUMCYP2D6 | |
| Acetylserotonin SCHEMBL7571473 | 0.86 | SPR (0.76) | SPRKDM4ECYP1A2NOTUMCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240254533-A1 | METHODS FOR PRODUCING TRYPTAMINE DERIVATIVES | OCTARINE BIO APS (DK) | 2024-08-01 | — | — | US | claimed |
| EP-4347856-A2 | METHODS FOR PRODUCING TRYPTAMINE DERIVATIVES | Octarine Bio ApS (DK) | 2024-04-10 | — | — | EP | claimed |
| WO-2023130076-A2 | TARGETS AND PATHWAYS FOR THE PRODUCTION OF ALKALOIDAL COMPOUNDS | Empyrean Neuroscience, Inc. (US) | 2023-07-06 | — | — | WO | claimed |
| WO-2023130078-A2 | GENETICALLY MODIFIED MYCELIUM FOR PRODUCING PSYCHOTROPIC ALKALOIDS | Empyrean Neuroscience, Inc. (US) | 2023-07-06 | — | — | WO | claimed |
| WO-2022248635-A2 | METHODS FOR PRODUCING TRYPTAMINE DERIVATIVES. | OCTARINE BIO APS (DK) | 2022-12-01 | — | — | WO | claimed |
| US-20260112544-A1 | ELECTROLYTIC CAPACITOR | PANASONIC IP MAN CO LTD (JP) | 2026-04-23 | — | — | US | disclosed |
| US-12531188-B2 | Electrolytic capacitor | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2026-01-20 | — | — | US | disclosed |
| US-20250346643-A1 | TROPOMYOSIN KINASE RECEPTOR (TRK) LIGANDS AS THERAPEUTICS TO SUPPORT LIVER REGENERATION | UNIV VANDERBILT (US) | 2025-11-13 | — | — | US | disclosed |
| EP-4638757-A1 | METHODS FOR THE PRODUCTION OF TRYPTOPHAN DERIVATIVES | Natural Medtech Pty Ltd (AU) | 2025-10-29 | — | — | EP | disclosed |
| CN-120195409-A | Composition for diagnosing sepsis and medicament for sepsis preventive treatment | 北京大学第三医院（北京大学第三临床医学院） | 2025-06-24 | — | — | CN | disclosed |
| US-20250171749-A1 | GENETICALLY MODIFIED ORGANISMS FOR PRODUCING PSYCHOTROPIC ALKALOIDS | Empyrean Neuroscience, Inc. | 2025-05-29 | — | — | US | disclosed |
| WO-2025099444-A1 | N-Acetylserotonin (NAS) Analogues | Beckley Psytech Limited (GB) | 2025-05-15 | — | — | WO | disclosed |
| WO-2022099424-A1 | ENGINEERED MICROORGANISMS FOR PRODUCING SUBSTITUTED TRYPTAMINES | ALGAE-C INC. (CA) | 2022-05-19 | — | — | WO | disclosed |
| WO-2022101482-A1 | MEANS AND METHODS FOR REGULATING INTRACELLULAR TRAFFICKING OF SECRETORY OR CELL MEMBRANE-ANCHORED PROTEINS OF INTEREST | HONING BIOSCIENCES (FR) | 2022-05-19 | — | — | WO | disclosed |
| CN-111304141-B | Recombinant escherichia coli for producing N-acetyl-5-hydroxytryptamine and construction method and application thereof | 中国科学院微生物研究所 | 2022-05-17 | — | — | CN | disclosed |
| EP-3983534-A1 | ADVANCED MICROBIOME THERAPEUTICS ENGINEERED TO PRODUCE SEROTONIN IN VIVO | Danmarks Tekniske Universitet (DK) | 2022-04-20 | — | — | EP | disclosed |
| WO-2022065434-A1 | ELECTROLYTIC CAPACITOR | パナソニックＩＰマネジメント株式会社 | 2022-03-31 | — | — | WO | disclosed |
| WO-2022032147-A1 | 2-AMINOINDANE COMPOUNDS FOR MENTAL DISORDERS OR ENHANCEMENT | TACTOGEN INC (US) | 2022-02-10 | — | — | WO | disclosed |
| WO-2022025189-A1 | ELECTROLYTIC CAPACITOR | パナソニックＩＰマネジメント株式会社 | 2022-02-03 | — | — | WO | disclosed |
| US-20220031641-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING COGNITIVE DYSFUNCTION | PHARMATROPHIX, INC. | 2022-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260112544-A1 | ELECTROLYTIC CAPACITOR | ASIC1, SLC9A2, SLC25A13 | SPR 3658/4885KDM4E 1446/4885CYP1A2 1225/4885 |
| US-20220031641-A1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING COGNITIVE DYSFUNCTION | CHRM3, CHAT, CHRM5 | SPR 2120/4885KDM4E 4449/4885CYP1A2 1535/4885 |
| US-12531188-B2 | Electrolytic capacitor | ASIC1, SLC1A2, HCN2 | SPR 4702/4885KDM4E 612/4885CYP1A2 2181/4885 |
| US-20250171749-A1 | GENETICALLY MODIFIED ORGANISMS FOR PRODUCING PSYCHOTROPIC ALKALOIDS | PNMT, INMT, AANAT | SPR 1506/4885KDM4E 754/4885CYP1A2 295/4885 |
| US-20250346643-A1 | TROPOMYOSIN KINASE RECEPTOR (TRK) LIGANDS AS THERAPEUTICS TO SUPPORT LIVER REGENERATION | HGF, HDGF, NTRK2 | SPR 793/4885KDM4E 4287/4885CYP1A2 3489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.